Sporotrichosis is a subcutaneous mycosis caused by Sporothrix and is globally distributed. 1 The pathogen of the disease is a dimorphic fungus, which can produce different morphological characteristics under different temperature conditions. Dimorphism is usually seen as a mould at room temperature in the natural environment, when infecting mammalian hosts, it presents a yeast-like phase, which can adapt to human body temperature. 2 As a result of basic and clinical research in genetic, ecological and biological diversities of Sporothrix sporotrichosis, a new taxonomic classification in Sporothrix is recommended: the 'clinical clade' includes S brasiliensis, S schenckii, S globosa and S luriei, and the remaining Sporothrix are nested in an 'environmental clade'. Species within 'clinical clade' varies in susceptibility, virulence and geographic distribution, and some isolates have been reported to be insensitive to itraconazole and other antifungal agents. 3-5 Identification and antifungal susceptibility testing play an increasingly important role in guiding appropriate therapeutic decision-making. But so far, there is no standard technique for most dimorphic fungi to determine their in vitro susceptibilities. 6 Yeast is the infective form of the pathogen in humans; however, most studies have used the filamentous form of